Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-based Dosing in Hemophilia A
NCT02586012Phase 2Terminated
- Start
- Sep 2015
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human coagulation factor VIII in hemophilia A. Started Sep 2015; status: terminated.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02586012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586012.